J&J | JNJ - PE Price to Earnings


J&J reported 29.43 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
AbbVie 23.96 0.93 Jun/2026
Abbott 23.85 1.08 Jun/2026
Amgen 18.07 1.77 Jun/2026
AstraZeneca 25.34 4.25 Jun/2026
Baxter International 151.95 65.95 Jun/2026
Bayer 4.14 0.74 Jun/2026
Becton, Dickinson and Co. 16.04 9.65 Jun/2026
Biogen 23.23 9.53 Jun/2026
Boston Scientific 17.86 14.49 Jun/2026
Bristol-Myers Squibb 16.14 7.06 Jun/2026
CONMED 9.39 17.48 Mar/2026
Cooper Companies 23.27 16.99 Mar/2026
Dexcom 24.61 0.12 Jun/2026
Edwards Lifesciences 30.77 3.9 Jun/2026
Eli Lilly 32.9 7.37 Jun/2026
Gilead Sciences 13.51 4.2 Jun/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
Globus Medical 22.31 12.99 Jun/2026
Insulet 29.66 9.17 Jun/2026
Integra LifeSciences 10.28 5.21 Jun/2026
Intuitive Surgical 44.59 11.23 Jun/2026
J&J 29.43 4.9 Jun/2026
Medtronic 19.66 3.1 Mar/2026
Merck 32.26 15.74 Jun/2026
Merit Medical Systems 32.36 12.84 Mar/2026
Novartis 22.41 2.24 Jun/2026
Pfizer 11.48 2.16 Jun/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sanofi 18.96 7.12 Jun/2026
Stryker 27.46 2.98 Jun/2026
Tandem Diabetes Care 681.05 189.32 Mar/2022
Teva Pharmaceutical Industries 24.6 14.53 Jun/2026
Vertex Pharmaceuticals 28.05 2.22 Jun/2026
Zimmer Biomet Holdings 17.33 8.14 Jun/2026
Zoetis 10.58 8.22 Jun/2026